RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.
2010-01-01 Mortara, Lorenzo; V., Frangione; Capone, Giacomo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy
2010-01-01 Frangione, V.; Mortara, L.; Castellani, P.; De Lerma Barbaro, A.; Accolla, R.
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.
2010-01-01 Mortara, Lorenzo; V., Frangione; P., Castellani; Capone, Giacomo; DE LERMA BARBARO, Andrea; Accolla, Roberto
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.
2006-01-01 Accolla, Roberto; Tosi, Giovanna; DE LERMA BARBARO, Andrea; P., Castellani; S., Ferrini; L., Zardi; Mortara, Lorenzo
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory
2010-01-01 Mortara, Lorenzo; Castellani, P.; Meazza, R.; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, F. A.; Comes, A.; Zardi, L.; Ferrini, S.; Accolla, Roberto
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3
2023-01-01 Cucchiara, Martina; Gallazzi, Matteo; Coco, Grace; Bombelli, RAFFAELLA MARIA; Olmeo, Francesca; Franzi, Francesca; Famoso, Graziana; Sessa, Fausto; Capogrosso, Paolo; Dehò, Federico; Bruno, Antonino; Mortara, Lorenzo
Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments
2022-01-01 Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Mortara, Lorenzo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino
Containment of SIV escape variants in vivo associated with highly macaque multispecific CTL vaccine induction
2001-01-01 Mortara, Lorenzo; P., Villefroy; F., Letourneur; J. G., Guillet; I., Bourgault Villada
Contribution of African green monkey, a primate model for resistance to AIDS, in the understanding of the lentivirus – dendritic cell interactions
2003-01-01 M. J. Y., Ploquin; O. M., Diop; N., SOL FOULON; Mortara, Lorenzo; A., Faye; M., Soares; A., Amara; O., Schwartz; F., BARRE SINOUSSI; M. C., MULLER TRUTWIN
Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA
2004-01-01 Meazza, R.; Mortara, Lorenzo; Comes, A.; DE LERMA BARBARO, Andrea; Tosi, Giovanna; Ferrini, S.; Accolla, Roberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy. | 1-gen-2010 | Mortara, Lorenzo; V., Frangione; Capone, Giacomo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto | |
| CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy | 1-gen-2010 | Frangione, V.; Mortara, L.; Castellani, P.; De Lerma Barbaro, A.; Accolla, R. | |
| CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy. | 1-gen-2010 | Mortara, Lorenzo; V., Frangione; P., Castellani; Capone, Giacomo; DE LERMA BARBARO, Andrea; Accolla, Roberto | |
| CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory. | 1-gen-2006 | Accolla, Roberto; Tosi, Giovanna; DE LERMA BARBARO, Andrea; P., Castellani; S., Ferrini; L., Zardi; Mortara, Lorenzo | |
| CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory | 1-gen-2010 | Mortara, Lorenzo; Castellani, P.; Meazza, R.; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, F. A.; Comes, A.; Zardi, L.; Ferrini, S.; Accolla, Roberto | |
| Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 | 1-gen-2023 | Cucchiara, Martina; Gallazzi, Matteo; Coco, Grace; Bombelli, RAFFAELLA MARIA; Olmeo, Francesca; Franzi, Francesca; Famoso, Graziana; Sessa, Fausto; Capogrosso, Paolo; Dehò, Federico; Bruno, Antonino; Mortara, Lorenzo | |
| Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments | 1-gen-2022 | Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Mortara, Lorenzo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino | |
| Containment of SIV escape variants in vivo associated with highly macaque multispecific CTL vaccine induction | 1-gen-2001 | Mortara, Lorenzo; P., Villefroy; F., Letourneur; J. G., Guillet; I., Bourgault Villada | |
| Contribution of African green monkey, a primate model for resistance to AIDS, in the understanding of the lentivirus – dendritic cell interactions | 1-gen-2003 | M. J. Y., Ploquin; O. M., Diop; N., SOL FOULON; Mortara, Lorenzo; A., Faye; M., Soares; A., Amara; O., Schwartz; F., BARRE SINOUSSI; M. C., MULLER TRUTWIN | |
| Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA | 1-gen-2004 | Meazza, R.; Mortara, Lorenzo; Comes, A.; DE LERMA BARBARO, Andrea; Tosi, Giovanna; Ferrini, S.; Accolla, Roberto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- Atti di Convegno 182
- Atti di Convegno::Abstract (in Vo... 107
- Atti di Convegno::Abstract (in Ri... 62
- Atti di Convegno::Poster 8
- Atti di Convegno::Relazione (in V... 5
Data di pubblicazione
- 2020 - 2023 11
- 2010 - 2019 49
- 2000 - 2009 102
- 1995 - 1999 20
Editore
- SIC Società Italiana di Cancerol... 1
Rivista
- MINERVA MEDICA 12
- MINERVA BIOTECNOLOGICA 9
- TUMORI 5
- ANNALES DE DERMATOLOGIE ET DE VEN... 4
- ANTIVIRAL THERAPY 4
- EUROPEAN JOURNAL OF CANCER 4
- RETROVIROLOGY 4
- TISSUE ANTIGENS 4
- EUROPEAN JOURNAL OF IMMUNOLOGY 3
- INTERNATIONAL IMMUNOLOGY 3
Keyword
- tumor angiogenesis 8
- NK cells 7
- Natural killer cells 5
- Natural Killer cells 3
- RNASET2 3
- VEGF 3
- Angiogenesis 2
- colorectal cancer 2
- cytotoxicity 2
- decidual-like NK cells 2
Lingua
- eng 22
Accesso al fulltext
- no fulltext 169
- reserved 10
- open 3